Ivabradine (Procoralan, Servier Laboratories) is a heart-rate-lowering agent that selectively and specifically inhibits..
Alteplase (Actilyse, Boehringer Ingelheim) is a tissue plasminogen activator manufactured by recombinant DNA technology...
The current estimate of the prevalence of atrial fibrillation (AF) in the developed world is approximately 1.5–2% of the..
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationAug 2012
The management of acute myocardial infarction continues to undergo major changes. Good practice should be based on sound..
Myocardial infarction (MI) can be recognised by clinical features, including electrocardiographic (ECG) findings,..
Deep vein thrombosis (DVT) of the lower limb veins and pulmonary embolism (PE) are the most commonly encountered..
Lower limb peripheral arterial disease (called peripheral arterial disease throughout this document) is a marker for..
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testingJun 2012
The current standard practice for the treatment of VTE is anticoagulation. These drugs “thin” the blood and prevent..
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathiesMay 2012
The objective of this guideline is to provide healthcare professionals with clear, up-to-date, and practical guidance on..
The aim of this document is to provide practical guidelines for the diagnosis, assessment, and treatment of acute and..
The aim of the 2012 guidelines from the Fifth Joint Task Force (JTF) of the European Societies on Cardiovascular Disease..
The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and..
This guideline focuses on the use of Apixaban for prevention of venous thromboembolism after total hip or knee..
European Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationNov 2011
The present document deals with the management of patients with suspected NSTE-ACS...
This guideline covers the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours in..
This clinical guideline (published August 2011) updates and replaces NICE clinical guideline 34 (published June 2006)...
This guideline offers best practice advice on the care of people with stable angina...
These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention...
Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower..
Cerebral vasculitis is an uncommon disorder that offers unusual problems for the neurologist. It is notoriously..
This guideline offers evidence-based advice on the diagnosis and treatment of Leg Ulcers and displays images of this..
The guideline identifies adult patient groups at risk of VTE and describes the available methods of prophylaxis...
Formulation of the best possible revascularization approach, taking into consideration the social and cultural context..
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in 1–2% of the general population...
This guideline provides evidence based recommendations on the management of venous leg ulcers and examines assessment,..
This guideline provides recommendations based on current evidence for best practice in the identification and management..
Management of patients with stroke: Rehabilitation, prevention and management of complications, and discharge planningJun 2010
The aim of this national guideline is to assist individual clinicians, primary care teams and hospital departments to..
Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular diseaseMar 2010
This guideline offers best practice advice on the care of adults at high risk of developing CVD or with established CVD...
The term ‘acute coronary syndromes’ encompasses a range of conditions from unstable angina to ST-segment-elevation..
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospitalJan 2010
This guideline examines the risk of venous thromboembolism and assesses the evidence for the effectiveness of primary..
Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospitalJan 2010
This guidance is about the care and treatment of people who are at risk of developing deep vein thrombosis (DVT) while..
An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC..
The aim of the present Task Force was to review the strength of evidence to support these interventions and the..
Syncope is a T-LOC due to transient global cerebral hypoperfusion characterized by rapid onset, short duration, and..
The Guidelines on the diagnosis and treatment of pulmonary hypertension (PH) are intended to provide the medical..
Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary preventionDec 2008
This guideline replaces SIGN 13 Management of patients with stroke I: Assessment, investigation, immediate management..
The task force for the diagnosis and management of Acute Pulmoanary Embolism of the European Society of Cardiology (ESC)..
The 2003 ESH/ESC Guidelines3 were well received by the clinical world and have been the most widely quoted paper in the..
Post Myocardial Infarction: Secondary prevention in primary and secondary care for patients following a myocardial infarctionMay 2007
This guideline is very welcome as it clearly emphasises the importance of exercise, smoking habit, diet and cardiac..
This guideline sets out best practice for the diagnosis and treatment of AF in both primary and secondary care. It also..